PubRank

Journal of skin cancer (J Skin Cancer)

Journal PubWeight™ 122.45‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Treatment of facial Basal cell carcinoma: a review. 2011 1.41
2 Basal cell carcinomas in gorlin syndrome: a review of 202 patients. 2010 1.34
3 Neglected Basal cell carcinomas in the 21st century. 2010 1.25
4 Which are the cells of origin in merkel cell carcinoma? 2012 1.21
5 Histopathological variants of cutaneous squamous cell carcinoma: a review. 2010 1.13
6 Cutaneous squamous cell carcinoma of the head and neck. 2011 1.09
7 A Troubling Diagnosis of Verrucous Squamous Cell Carcinoma ("the Bad Kind" of Keratosis) and the Need of Clinical and Pathological Correlations: A Review of the Literature with a Case Report. 2010 1.08
8 Basal cell carcinoma: from the molecular understanding of the pathogenesis to targeted therapy of progressive disease. 2010 1.06
9 Safety and efficacy of 188-rhenium-labeled antibody to melanin in patients with metastatic melanoma. 2013 1.02
10 Molecular Network Associated with MITF in Skin Melanoma Development and Progression. 2011 1.01
11 Worldwide increasing incidences of cutaneous malignant melanoma. 2011 0.99
12 Basal cell carcinoma of the head and neck. 2010 0.98
13 Uveal melanoma. 2011 0.98
14 Histological, immunohistological, and clinical features of merkel cell carcinoma in correlation to merkel cell polyomavirus status. 2012 0.96
15 Focus on Basal cell carcinoma. 2010 0.96
16 Histopathological study of skin adnexal tumours-institutional study in South India. 2014 0.96
17 Basal cell carcinoma of the head and neck region: an analysis of 171 cases. 2012 0.93
18 Merkel cell carcinoma: the past, the present, and the future. 2013 0.92
19 Simulators of squamous cell carcinoma of the skin: diagnostic challenges on small biopsies and clinicopathological correlation. 2013 0.91
20 Inhibition of Epidermal Growth Factor Receptor and PI3K/Akt Signaling Suppresses Cell Proliferation and Survival through Regulation of Stat3 Activation in Human Cutaneous Squamous Cell Carcinoma. 2010 0.91
21 Reconstruction of nasal skin cancer defects with local flaps. 2011 0.90
22 Sociodemographic and Psychological Correlates of Sun Protection Behaviors among Outdoor Workers: A Review. 2013 0.89
23 AP1 transcription factors in epidermal differentiation and skin cancer. 2013 0.89
24 Locally advanced and unresectable cutaneous squamous cell carcinoma: outcomes of concurrent cetuximab and radiotherapy. 2014 0.88
25 Imaging in patients with merkel cell carcinoma. 2013 0.88
26 Nonsurgical treatment options for Basal cell carcinoma. 2011 0.87
27 Rising incidence of mucosal melanoma of the head and neck in the United States. 2012 0.87
28 Neurotropic melanoma: the management of localised disease. 2012 0.86
29 Treatment patterns in patients with metastatic melanoma: a retrospective analysis. 2014 0.86
30 Basal cell carcinoma: 10 years of experience. 2010 0.86
31 The pink rim sign: location of pink as an indicator of melanoma in dermoscopic images. 2014 0.86
32 Pre-treatment deep curettage can significantly reduce tumour thickness in thick Basal cell carcinoma while maintaining a favourable cosmetic outcome when used in combination with topical photodynamic therapy. 2011 0.86
33 Role of stat3 in skin carcinogenesis: insights gained from relevant mouse models. 2013 0.86
34 A clinicopathological and immunohistochemical correlation in cutaneous metastases from internal malignancies: a five-year study. 2014 0.86
35 Merkel cell carcinoma: chemotherapy and emerging new therapeutic options. 2013 0.86
36 Evaluation of the definitions of "high-risk" cutaneous squamous cell carcinoma using the american joint committee on cancer staging criteria and national comprehensive cancer network guidelines. 2014 0.86
37 Sun Protection Beliefs among Hispanics in the US. 2014 0.86
38 Two distinct pathways to development of squamous cell carcinoma of the vulva. 2010 0.85
39 Ulcerative granular cell tumor: a clinicopathological and immunohistochemical study. 2011 0.85
40 Mycosis fungoides in Iranian population: an epidemiological and clinicopathological study. 2015 0.85
41 Gender-Based Differences and Barriers in Skin Protection Behaviors in Melanoma Survivors. 2016 0.85
42 Sentinel lymph node biopsy in nonmelanoma skin cancer patients. 2013 0.84
43 H3K79me3T80ph is a Novel Histone Dual Modification and a Mitotic Indicator in Melanoma. 2012 0.84
44 Characterization of the Merkel Cell Carcinoma miRNome. 2014 0.84
45 Merkel cell carcinoma: interdisciplinary management of a rare disease. 2013 0.83
46 Potential role of meiosis proteins in melanoma chromosomal instability. 2013 0.83
47 e-Health Tools for Targeting and Improving Melanoma Screening: A Review. 2012 0.83
48 Multiple roles for VEGF in non-melanoma skin cancer: angiogenesis and beyond. 2012 0.83
49 Principles of Periocular Reconstruction following Excision of Cutaneous Malignancy. 2012 0.83
50 Comorbidity Assessment in Skin Cancer Patients: A Pilot Study Comparing Medical Interview with a Patient-Reported Questionnaire. 2015 0.83
Next 50